Imricor Medical Systems Stock Shares Outstanding
| IMR Stock | 1.14 0.02 1.72% |
Imricor Medical Systems fundamentals help investors to digest information that contributes to Imricor Medical's financial success or failures. It also enables traders to predict the movement of Imricor Stock. The fundamental analysis module provides a way to measure Imricor Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imricor Medical stock.
Common Stock Shares Outstanding is likely to drop to about 128.8 M in 2024. Imricor | Shares Outstanding |
Imricor Medical Systems Company Shares Outstanding Analysis
Imricor Medical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Imricor Medical Shares Outstanding | 270.18 M |
Most of Imricor Medical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Imricor Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Imricor Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Imricor Medical Systems has 270.18 M of shares currently outstending. This is 49.65% higher than that of the Health Care Equipment & Supplies sector and 54.43% higher than that of the Health Care industry. The shares outstanding for all Australia stocks is 52.75% higher than that of the company.
Imricor Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imricor Medical's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Imricor Medical could also be used in its relative valuation, which is a method of valuing Imricor Medical by comparing valuation metrics of similar companies.Imricor Medical is currently under evaluation in shares outstanding category among its peers.
Imricor Fundamentals
| Return On Equity | -2.75 | ||||
| Return On Asset | -1.25 | ||||
| Operating Margin | (19.77) % | ||||
| Current Valuation | 328.6 M | ||||
| Shares Outstanding | 270.18 M | ||||
| Shares Owned By Insiders | 20.26 % | ||||
| Shares Owned By Institutions | 14.56 % | ||||
| Price To Book | 3.97 X | ||||
| Price To Sales | 370.37 X | ||||
| Revenue | 615.57 K | ||||
| Gross Profit | (1.53 M) | ||||
| EBITDA | (21.87 M) | ||||
| Net Income | (34.09 M) | ||||
| Total Debt | 10.42 M | ||||
| Book Value Per Share | (0.03) X | ||||
| Cash Flow From Operations | (19.55 M) | ||||
| Earnings Per Share | (0.17) X | ||||
| Target Price | 0.71 | ||||
| Beta | 0.25 | ||||
| Market Capitalization | 305.3 M | ||||
| Total Asset | 8.31 M | ||||
| Retained Earnings | (165 M) | ||||
| Working Capital | (628.21 K) | ||||
| Net Asset | 8.31 M |
About Imricor Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imricor Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imricor Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imricor Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imricor Stock Analysis
When running Imricor Medical's price analysis, check to measure Imricor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imricor Medical is operating at the current time. Most of Imricor Medical's value examination focuses on studying past and present price action to predict the probability of Imricor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imricor Medical's price. Additionally, you may evaluate how the addition of Imricor Medical to your portfolios can decrease your overall portfolio volatility.